These projects were made possible from Cure Alzheimer's Fund support.
Project Description | Researchers | Funding |
---|---|---|
Reversal of Tau Pathology by an Adenosine A1 Receptor Antagonist |
2018, 2020 $575,000 |
|
Tau Missorting in AD—Causes and Consequences |
2015, 2017 $322,500 |